FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40601211000001100: Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
67791000001113 Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
67801000001112 Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Has VMP Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zubsolv 1.4mg/0.36mg sublingual tablets (Accord Healthcare Ltd) 28 tablet 4 x 7 tablets Is a True Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start